Taiwan-Based Bora Pharmaceuticals Plans Manufacturing Complex in Mississauga, Ontario, Canada
Establishing the Mississauga site as part of its global manufacturing network is key to Bora Pharmaceuticals' growth strategy. From its new facility, Bora Pharmaceuticals is now positioned to produce 50 different products for 100 markets worldwide.
"This expansion into North America brings us closer to many of our customers and adds the capabilities to welcome new ones onboard," said Bobby Sheng, CEO of Bora Pharmaceuticals. "The Mississauga site strengthens our existing state-of-the-art manufacturing network, whilst adding a number of talented colleagues that will help us develop further in the region."
Through its acquisition of GSK's Mississauga facility, which is now complete, the company has taken a major step forward with its expansion into North America. Bora Pharmaceuticals will employ approximately 400 skilled manufacturing employees from their Mississauga site and plans to recruit additional employees to further strengthen its technical and operations team.
"We are so pleased that Bora Pharmaceuticals' North American operations will be headquartered in Mississauga," said Bonnie Brown, Director of Economic Development. "With more than 470 businesses and over 25,000 employees already working in our thriving life sciences sector, including key contract development and manufacturing organizations, we remain steadfast in our commitment to creating a sustainable environment that supports bringing medical innovation to market in Mississauga that will benefit the world."
Ninth Avenue Foods Establishes Columbus, Indiana, Midwest Headquarters and Production Hub
What’s Driving Record Industrial Real Estate Demand
2020 Top States for Doing Business Showcase Their Pro-Business Environments
2020 Gold & Silver Shovel Awards Recognize State and Local Economic Development Efforts
Pandemic Fuels Data Center Growth
Regional Report: Southeast Ports Expand Capacity
Trends in Office and Industrial Parks